{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:53:56Z","timestamp":1792043636745,"version":"4.4.0"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oral. Health"],"abstract":"<jats:p>The number of cancer survivors are increasing and so are the oral toxicities from cancer therapy. Most patients receiving treatment for cancer develop some form of oral adverse events including, but not limited to, mucositis, opportunistic infections, dry mouth, and\/or osteonecrosis of the jaw. One of the most common complications from head and neck cancer radiation therapy is salivary gland dysfunction (SGD). SGD is an umbrella term that includes the subjective sensation of dry mouth (xerostomia) and hyposalivation (objective reduction of the salivary flow rate). Dry mouth in cancer patients may lead to functional defects (e.g., eating, speaking, and swallowing), increase the risk of dental caries and oral candidiasis, and can have a negative effect on the nutritional and psychological status of the patients. The aim of this mini review was to summarize the current criteria for diagnosis and management of SGD associated with cancer treatment.<\/jats:p>","DOI":"10.3389\/froh.2022.907778","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T04:47:07Z","timestamp":1654750027000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Salivary Gland Dysfunction Secondary to Cancer Treatment"],"prefix":"10.3389","volume":"3","author":[{"given":"Anette","family":"Vistoso Monreal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Polonsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Shiboski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya","family":"Sankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1056\/NEJMra1712502","article-title":"Cancer survivorship","volume":"379","author":"Shapiro","year":"2018","journal-title":"N Engl J Med."},{"key":"B2","unstructured":"2021"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3322\/caac.21157","article-title":"Oral complications of cancer and cancer therapy: from cancer treatment to survivorship","volume":"62","author":"Epstein","year":"2012","journal-title":"CA Cancer J Clin."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1007\/s00520-015-2720-y","article-title":"Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients","volume":"23","author":"Mercadante","year":"2015","journal-title":"Support Care Cancer."},{"key":"B6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.archoralbio.2015.03.004","article-title":"The functions of human saliva: a review sponsored by the world workshop on oral medicine VI","volume":"60","author":"Dawes","year":"2015","journal-title":"Arch Oral Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40268-016-0153-9","article-title":"A Guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the world workshop on oral medicine VI","volume":"17","author":"Wolff","year":"2017","journal-title":"Drugs R D."},{"key":"B8","first-page":"303","article-title":"Saliva between normal and pathological. important factors in determining systemic and oral health","volume":"2","author":"Iorgulescu","year":"2009","journal-title":"J Med Life."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1177\/00220345920710070301","article-title":"Clinical criteria for the diagnosis of salivary gland hypofunction","volume":"71","author":"Navazesh","year":"1992","journal-title":"J Dent Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1177\/00220345000790111001","article-title":"Determination of variation of stimulated salivary flow rates","volume":"79","author":"Ghezzi","year":"2000","journal-title":"J Dent Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00520-010-0827-8","article-title":"A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life","volume":"18","author":"Jensen","year":"2010","journal-title":"Support Care Cancer."},{"key":"B12","unstructured":""},{"key":"B13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ijrobp.2006.05.002","article-title":"Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer","volume":"66","author":"Meirovitz","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/cdoe.12504","article-title":"Degrees of xerostomia? a rasch analysis of the xerostomia inventory community","volume":"48","author":"Santiago","year":"2020","journal-title":"Dent Oral Epidemiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.21037\/apm.2020.02.34","article-title":"When saliva becomes a problem: the challenges and palliative care for patients with sialorrhea","volume":"9","author":"Paine","year":"2020","journal-title":"Ann Palliat Med."},{"key":"B16","first-page":"859","article-title":"Mucolytics, expectorants, and mucokinetic medications","volume":"52","author":"Rubin","year":"2007","journal-title":"Respir Care."},{"key":"B17","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1177\/0022034509343143","article-title":"Sensitivity of salivary glands to radiation: from animal models to therapies","volume":"88","author":"Grundmann","year":"2009","journal-title":"J Dent Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.oraloncology.2016.12.031","article-title":"Interventions for the management of radiotherapy-induced xerostomia and hyposalivation: a systematic review and meta-analysis","volume":"66","author":"Mercadante","year":"2017","journal-title":"Oral Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.ijrobp.2009.06.090","article-title":"Radiotherapy dose-volume effects on salivary gland function","volume":"76","author":"Deasy","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B20","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00520-010-0856-3","article-title":"Systematic reviews of oral complications from cancer therapies, oral care study group, MASCC\/ISOO: methodology and quality of the literature","volume":"18","author":"Brennan","year":"2010","journal-title":"Support Care Cancer."},{"key":"B21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1748-717X-1-18","article-title":"3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing","volume":"1","author":"Wendt","year":"2006","journal-title":"Radiation Oncology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1007\/s00520-019-05132-1","article-title":"Alleviation of dry mouth by saliva substitutes improved swallowing ability and clinical nutritional status of post-radiotherapy head and neck cancer patients: a randomized controlled trial","volume":"28","author":"Nuchit","year":"2020","journal-title":"Supportive Care Cancer."},{"key":"B23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000502979","article-title":"Use of amifostine for cytoprotection during radiation therapy: a review","volume":"98","author":"King","year":"2020","journal-title":"Oncology."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(95)00145-9","article-title":"Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR-2721): preclinical aspects","author":"Peters","year":"1995","journal-title":"Eur J Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e355","DOI":"10.4317\/medoral.20969","article-title":"Treatment of xerostomia and hyposalivation in the elderly: a systematic review","volume":"21","author":"Gil-Montoya","year":"2016","journal-title":"Med Oral Patol Oral Cir Bucal."},{"key":"B26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archinte.159.2.174","article-title":"Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sj\u00f6gren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial P92-01 study group","volume":"159","author":"Vivino","year":"1999","journal-title":"Arch Intern Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1001\/archinte.162.11.1293","article-title":"Cevimeline for the treatment of xerostomia in patients with Sj\u00f6gren syndrome: a randomized trial","volume":"162","author":"Fife","year":"2002","journal-title":"Arch Intern Med."},{"key":"B28","article-title":"CADTH Rapid Response Reports","volume-title":"Pilocarpine for Sj\u00f6gren's Syndrome-Induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines","author":"Freige","year":"2020"},{"key":"B29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1470-2045(06)70580-0","article-title":"Oral complications of radiotherapy","volume":"7","author":"Sciubba","year":"2006","journal-title":"Lancet Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1916910","DOI":"10.1001\/jamanetworkopen.2019.16910","article-title":"Effect of true and sham acupuncture on radiation-induced xerostomia among patients with head and neck cancer: a randomized clinical trial","volume":"2","author":"Garcia","year":"2019","journal-title":"JAMA Netw Open."},{"key":"B31","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1089\/pho.2016.4104","article-title":"Low-Level laser for mitigation of low salivary flow rate in head and neck cancer patients undergoing radiochemotherapy: a prospective longitudinal study","volume":"34","author":"Gonnelli","year":"2016","journal-title":"Photomed Laser Surg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/JCO.21.01208","article-title":"Salivary gland hypofunction and\/or xerostomia induced by nonsurgical cancer therapies: ISOO\/MASCC\/ASCO Guideline","volume":"39","author":"Mercadante","year":"2021","journal-title":"J Clin Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1517\/14712598.2015.1064894","article-title":"Advances in salivary gland gene therapy \u2013 oral and systemic implications","volume":"15","author":"Baum","year":"2015","journal-title":"Expert Opin Biol Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1182\/asheducation-2008.1.134","article-title":"Recognizing and managing chronic graft-versus-host disease","volume":"2008","author":"Lee","year":"2008","journal-title":"Hematology."},{"key":"B35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: i. the 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.bbmt.2010.03.023","article-title":"Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation","volume":"16","author":"Imanguli","year":"2010","journal-title":"Biol Blood Marrow Trans."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1182\/blood-2012-05-393389","article-title":"How we treat oral chronic graft-versus-host disease","volume":"120","author":"Treister","year":"2012","journal-title":"Blood."},{"key":"B38","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jtct.2021.02.020","article-title":"Use of prescription sialagogues for management of xerostomia in chronic graft-versus-host-disease","volume":"27","author":"Mousavian","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/j.bbmt.2020.06.031","article-title":"Histopathological grading of oral mucosal chronic graft-versus-host disease: large cohort analysis","volume":"26","author":"Tollemar","year":"2020","journal-title":"Biol Blood Marrow Trans."},{"key":"B40","first-page":"82","article-title":"Superficial mucoceles in chronic graft-versus-host disease: a case report and review of the literature","volume":"57","author":"Balasubramaniam","year":"2009","journal-title":"Gen Dent."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e20190785","DOI":"10.1590\/0034-7167-2019-0785","article-title":"Prevalence of xerostomia in women during breast cancer chemotherapy","volume":"73","author":"Pinto","year":"2020","journal-title":"Rev Bras Enferm."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1002\/cncr.33436","article-title":"Oral side effects of immune checkpoint inhibitor therapy (ICIT): an analysis of 4683 patients receiving ICIT for malignancies at Massachusetts general hospital, brigham & women's hospital, and the dana-farber cancer institute, 2011 to 2019","volume":"127","author":"Xu","year":"2021","journal-title":"Cancer."},{"key":"B43","article-title":"Oral toxicity","volume-title":"The Chemotherapy Source Book","author":"Peterson","year":"2001"},{"key":"B44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1601-5037.2008.00326.x","article-title":"Comparison of the effects of pilocarpine and cevimeline on salivary flow","volume":"7","author":"Braga","year":"2009","journal-title":"Int J Dent Hyg."},{"key":"B45","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nature Reviews Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-Related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat Rev Clin Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1634\/theoncologist.2018-0823","article-title":"Sicca syndrome associated with immune checkpoint inhibitor therapy","volume":"24","author":"Warner","year":"2019","journal-title":"Oncologist."},{"key":"B49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/odi.13964","article-title":"Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors","volume":"28","author":"Klein","year":"2022","journal-title":"Oral Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00520-021-06535-9","article-title":"Xerostomia: an immunotherapy-related adverse effect in cancer patients","volume":"30","author":"Bustillos","year":"2022","journal-title":"Supportive Care Cancer."},{"key":"B51","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.oraloncology.2015.06.009","article-title":"Dental demineralization and caries in patients with head and neck cancer","volume":"51","author":"Deng","year":"2015","journal-title":"Oral Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.bbmt.2012.04.009","article-title":"Extensive dental caries in patients with oral chronic graft-versus-host disease","volume":"18","author":"Castellarin","year":"2012","journal-title":"Biol Blood Marrow Transplant."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e25540","DOI":"10.1097\/MD.0000000000025540","article-title":"The effect of comprehensive oral care program on oral health and quality of life in patients undergoing radiotherapy for head and neck cancer: a quasi-experimental case-control study","volume":"100","author":"Lee","year":"2021","journal-title":"Medicine (Baltimore)."},{"key":"B54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1079-2104(97)90061-5","article-title":"Jr","volume":"84","author":"Ramirez-Amador","year":"1997","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod."},{"key":"B55","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00520-010-0892-z","article-title":"A systematic review of oral fungal infections in patients receiving cancer therapy","volume":"18","author":"Lalla","year":"2010","journal-title":"Supportive Care Cancer."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1111\/odi.13151","article-title":"OralCandidacolonization in xerostomic postradiotherapy head and neck cancer patients","volume":"25","author":"Tarapan","year":"2019","journal-title":"Oral Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management candidiasis: 2009 update by the infectious diseases society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/jpm.2016.0381","article-title":"Prophylactic feeding tubes in head and neck cancers #318","volume":"19","author":"Hardy","year":"2016","journal-title":"J Palliat Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0360-3016(91)90132-N","article-title":"Elapsed treatment days\u2013a critical item for radiotherapy quality control review in head and neck trials: RTOG report","volume":"20","author":"Pajak","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B60","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/nu7010265","article-title":"Nutritional interventions in head and neck cancer patients undergoing chemoradiotherapy: a narrative review","volume":"7","author":"Bossola","year":"2015","journal-title":"Nutrients."},{"key":"B61","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.oraloncology.2012.10.004","article-title":"Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy","volume":"49","author":"Xiao","year":"2013","journal-title":"Oral Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1470-2045(13)70244-4","article-title":"Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis","volume":"14","author":"Mitchell","year":"2013","journal-title":"Lancet Oncol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"84","DOI":"10.18773\/austprescr.2016.035","article-title":"Oral and dental effects of antidepressants","volume":"39","author":"Daly","year":"2016","journal-title":"Aust Prescr."},{"key":"B64","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.pnpbp.2017.12.012","article-title":"Meta-analysis: risk of dry mouth with second generation antidepressants","volume":"84","author":"Cappetta","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B65","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1001\/jamaoto.2013.3371","article-title":"Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial","volume":"139","author":"Lydiatt","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg."}],"container-title":["Frontiers in Oral Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/froh.2022.907778\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T04:47:15Z","timestamp":1654750035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/froh.2022.907778\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":65,"alternative-id":["10.3389\/froh.2022.907778"],"URL":"https:\/\/doi.org\/10.3389\/froh.2022.907778","relation":{},"ISSN":["2673-4842"],"issn-type":[{"value":"2673-4842","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"article-number":"907778"}}